Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

The Quasi-uniform assumption for Spinal Cord Stimulation translational research.

Khadka N, Truong DQ, Williams P, Martin JH, Bikson M.

J Neurosci Methods. 2019 Oct 4;328:108446. doi: 10.1016/j.jneumeth.2019.108446. [Epub ahead of print]

PMID:
31589892
2.

Reply.

Hayward KL, Valery PC, Cottrell WN, Irvine KM, Martin JH, Powell EE.

Hepatol Commun. 2019 Jul 10;3(9):1283-1284. doi: 10.1002/hep4.1398. eCollection 2019 Sep. No abstract available.

3.

Clinically Optimal Versus "Target" Doses in Heart Failure.

Dimmitt SB, Martin JH.

J Am Coll Cardiol. 2019 Sep 10;74(10):1425. doi: 10.1016/j.jacc.2019.06.062. No abstract available.

PMID:
31488283
4.

Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.

Dryburgh LM, Martin JH.

Ther Drug Monit. 2019 Aug 29. doi: 10.1097/FTD.0000000000000698. [Epub ahead of print]

PMID:
31479044
5.

Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis.

Dimmitt SB, Martin JH.

Med J Aust. 2019 Sep;211(6):284-284.e1. doi: 10.5694/mja2.50324. Epub 2019 Aug 22. No abstract available.

PMID:
31441063
6.

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes.

Wright DFB, Martin JH, Cremers S.

Br J Clin Pharmacol. 2019 Oct;85(10):2238-2240. doi: 10.1111/bcp.14050. Epub 2019 Aug 9. No abstract available.

PMID:
31400011
7.

Dominant-negative SOX9 mutations in campomelic dysplasia.

Csukasi F, Duran I, Zhang W, Martin JH, Barad M, Bamshad M, Weis MA, Eyre D, Krakow D, Cohn DH.

Hum Mutat. 2019 Aug 7. doi: 10.1002/humu.23888. [Epub ahead of print]

PMID:
31389106
8.

Neuronal activity and microglial activation support corticospinal tract and proprioceptive afferent sprouting in spinal circuits after a corticospinal system lesion.

Jiang YQ, Armada K, Martin JH.

Exp Neurol. 2019 Nov;321:113015. doi: 10.1016/j.expneurol.2019.113015. Epub 2019 Jul 18.

PMID:
31326353
9.

Parasitic pharmacology: A plausible mechanism of action for cannabidiol.

Groeneveld GJ, Martin JH.

Br J Clin Pharmacol. 2019 Jul 10. doi: 10.1111/bcp.14028. [Epub ahead of print] No abstract available.

PMID:
31290177
10.

Optimising low-dose methotrexate for rheumatoid arthritis-A review.

Lucas CJ, Dimmitt SB, Martin JH.

Br J Clin Pharmacol. 2019 Oct;85(10):2228-2234. doi: 10.1111/bcp.14057. Epub 2019 Aug 9. Review.

PMID:
31276602
11.

Model-based analysis on systemic availability of coadministered cannabinoids after controlled vaporised administration.

Liu Z, Galettis P, Broyd SJ, van Hell H, Greenwood LM, de Krey P, Steigler A, Zhu X, Schneider J, Solowij N, Martin JH.

Intern Med J. 2019 Jul 1. doi: 10.1111/imj.14415. [Epub ahead of print]

PMID:
31264294
12.

Diving, cannabis use, and techniques of neutralisation: exploring how divers rationalise cannabis use.

Martin JH, Van Wijk CH, Bowden WJ.

Int Marit Health. 2019;70(2):88-94. doi: 10.5603/IMH.2019.0014.

13.

Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.

Dimmitt SB, Stampfer HG, Martin JH, Ferner RE.

Br J Clin Pharmacol. 2019 Oct;85(10):2218-2227. doi: 10.1111/bcp.14033. Epub 2019 Aug 19. Review.

PMID:
31219198
14.

Independent replication of motor cortex and cervical spinal cord electrical stimulation to promote forelimb motor function after spinal cord injury in rats.

Yang Q, Ramamurthy A, Lall S, Santos J, Ratnadurai-Giridharan S, Lopane M, Zareen N, Alexander H, Ryan D, Martin JH, Carmel JB.

Exp Neurol. 2019 Oct;320:112962. doi: 10.1016/j.expneurol.2019.112962. Epub 2019 May 21.

PMID:
31125548
15.

The rationale of dose-response curves in selecting cancer drug dosing.

Martin JH, Dimmitt S.

Br J Clin Pharmacol. 2019 Oct;85(10):2198-2204. doi: 10.1111/bcp.13979. Epub 2019 Jun 20. Review.

PMID:
31077412
16.

Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention.

Hayward KL, Patel PJ, Valery PC, Horsfall LU, Li CY, Wright PL, Tallis CJ, Stuart KA, Irvine KM, Cottrell WN, Martin JH, Powell EE.

Hepatol Commun. 2019 Mar 18;3(5):620-631. doi: 10.1002/hep4.1334. eCollection 2019 May.

17.

Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribers.

Martin JH, Talley NJ.

Br J Clin Pharmacol. 2019 Aug;85(8):1664-1665. doi: 10.1111/bcp.13963. Epub 2019 May 23. No abstract available.

PMID:
30980683
18.

Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain.

Patel J, Lucas CJ, Margalit M, Martin JH.

J Pain Palliat Care Pharmacother. 2018 Jun - Sep;32(2-3):116-123. doi: 10.1080/15360288.2018.1545725. Epub 2019 Feb 8.

PMID:
30735070
19.

Investigation into the presence and functional significance of proinsulin C-peptide in the female germline†.

Martin JH, Aitken RJ, Bromfield EG, Cafe SL, Sutherland JM, Frost ER, Nixon B, Lord T.

Biol Reprod. 2019 May 1;100(5):1275-1289. doi: 10.1093/biolre/ioz008.

PMID:
30715203
20.

Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.

Nicoletti P, Aithal GP, Chamberlain TC, Coulthard S, Alshabeeb M, Grove JI, Andrade RJ, Bjornsson E, Dillon JF, Hallberg P, Lucena MI, Maitland-van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Wadelius M, Shen Y, Nelson MR, Daly AK; International Drug-Induced Liver Injury Consortium (iDILIC).

Clin Pharmacol Ther. 2019 Jul;106(1):245-253. doi: 10.1002/cpt.1375. Epub 2019 Mar 19.

PMID:
30661239
21.

"I'm a Survivor": Aboriginal and Torres Strait Islander Cancer Survivors' Perspectives of Cancer Survivorship.

Meiklejohn JA, Bailie R, Adams J, Garvey G, Bernardes CM, Williamson D, Marcusson B, Arley B, Martin JH, Walpole ET, Valery PC.

Cancer Nurs. 2018 Dec 12. doi: 10.1097/NCC.0000000000000671. [Epub ahead of print]

PMID:
30543569
22.

DNA damage and repair in the female germline: contributions to ART.

Martin JH, Aitken RJ, Bromfield EG, Nixon B.

Hum Reprod Update. 2019 Mar 1;25(2):180-201. doi: 10.1093/humupd/dmy040.

PMID:
30541031
23.

The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.

Csukasi F, Duran I, Barad M, Barta T, Gudernova I, Trantirek L, Martin JH, Kuo CY, Woods J, Lee H, Cohn DH, Krejci P, Krakow D.

Sci Transl Med. 2018 Sep 19;10(459). pii: eaat9356. doi: 10.1126/scitranslmed.aat9356.

PMID:
30232230
24.

Optimal cancer drug dosing in adolescents: new issues and the old unaddressed ones.

Ryan J, Patel J, Lucas CJ, Martin JH.

Intern Med J. 2018 Sep;48(9):1023-1027. doi: 10.1111/imj.14020. No abstract available.

PMID:
30182398
25.

Care and concern with cannabinoids used therapeutically.

Martin JH, Cranswick N.

Br J Clin Pharmacol. 2018 Nov;84(11):2455-2457. doi: 10.1111/bcp.13724. Epub 2018 Aug 22. No abstract available.

PMID:
30136416
26.

Modification of Crocodile Spermatozoa Refutes the Tenet That Post-testicular Sperm Maturation Is Restricted To Mammals.

Nixon B, Johnston SD, Skerrett-Byrne DA, Anderson AL, Stanger SJ, Bromfield EG, Martin JH, Hansbro PM, Dun MD.

Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S59-S76. doi: 10.1074/mcp.RA118.000904. Epub 2018 Aug 2.

PMID:
30072580
27.

Transneuronal Downregulation of the Premotor Cholinergic System After Corticospinal Tract Loss.

Jiang YQ, Sarkar A, Amer A, Martin JH.

J Neurosci. 2018 Sep 26;38(39):8329-8344. doi: 10.1523/JNEUROSCI.3410-17.2018. Epub 2018 Jul 26.

28.

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Dryburgh LM, Bolan NS, Grof CPL, Galettis P, Schneider J, Lucas CJ, Martin JH.

Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. doi: 10.1111/bcp.13695. Epub 2018 Aug 1. Review.

PMID:
29953631
29.

Double Strand Break DNA Repair occurs via Non-Homologous End-Joining in Mouse MII Oocytes.

Martin JH, Bromfield EG, Aitken RJ, Lord T, Nixon B.

Sci Rep. 2018 Jun 26;8(1):9685. doi: 10.1038/s41598-018-27892-2.

30.

GlpR Is a Direct Transcriptional Repressor of Fructose Metabolic Genes in Haloferax volcanii.

Martin JH, Sherwood Rawls K, Chan JC, Hwang S, Martinez-Pastor M, McMillan LJ, Prunetti L, Schmid AK, Maupin-Furlow JA.

J Bacteriol. 2018 Aug 10;200(17). pii: e00244-18. doi: 10.1128/JB.00244-18. Print 2018 Sep 1.

31.

Community-identified recommendations to enhance cancer survivorship for Aboriginal and Torres Strait Islander people.

Meiklejohn JA, Arley B, Bailie R, Adams J, Garvey G, Martin JH, Walpole ET, Valery PC.

Aust J Prim Health. 2018 Jul;24(3):233-240. doi: 10.1071/PY17127.

PMID:
29804561
32.

Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Liu Z, Martin JH.

Br J Clin Pharmacol. 2018 Nov;84(11):2483-2487. doi: 10.1111/bcp.13635. Epub 2018 Jun 7. Review.

PMID:
29766540
33.

Stimulation-dependent remodeling of the corticospinal tract requires reactivation of growth-promoting developmental signaling pathways.

Zareen N, Dodson S, Armada K, Awad R, Sultana N, Hara E, Alexander H, Martin JH.

Exp Neurol. 2018 Sep;307:133-144. doi: 10.1016/j.expneurol.2018.05.004. Epub 2018 May 2.

34.
35.

Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users.

Beale C, Broyd SJ, Chye Y, Suo C, Schira M, Galettis P, Martin JH, Yücel M, Solowij N.

Cannabis Cannabinoid Res. 2018 Apr 1;3(1):94-107. doi: 10.1089/can.2017.0047. eCollection 2018.

36.

Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial.

Solowij N, Broyd SJ, Beale C, Prick JA, Greenwood LM, van Hell H, Suo C, Galettis P, Pai N, Fu S, Croft RJ, Martin JH, Yücel M.

Cannabis Cannabinoid Res. 2018 Mar 1;3(1):21-34. doi: 10.1089/can.2017.0043. eCollection 2018.

37.

Clinical benefits of evolocumab appear less than hoped.

Dimmitt SB, Stampfer HG, Martin JH, Warren JB.

Lancet. 2018 Mar 10;391(10124):933-934. doi: 10.1016/S0140-6736(18)30530-0. No abstract available.

PMID:
29536851
38.

Author Correction: Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction?

Martin JH, Schneider J, Lucas CJ, Galettis P.

Clin Pharmacokinet. 2018 May;57(5):645. doi: 10.1007/s40262-018-0633-x.

PMID:
29468560
39.

Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of Physicians.

Martin JH, Bonomo Y, Reynolds AD.

Med J Aust. 2018 Feb 19;208(3):107-109. No abstract available.

PMID:
29438641
40.

Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies.

Kunova Bosakova M, Varecha M, Hampl M, Duran I, Nita A, Buchtova M, Dosedelova H, Machat R, Xie Y, Ni Z, Martin JH, Chen L, Jansen G, Krakow D, Krejci P.

Hum Mol Genet. 2018 Mar 15;27(6):1093-1105. doi: 10.1093/hmg/ddy031.

41.

Heat exposure induces oxidative stress and DNA damage in the male germ line.

Houston BJ, Nixon B, Martin JH, De Iuliis GN, Trigg NA, Bromfield EG, McEwan KE, Aitken RJ.

Biol Reprod. 2018 Apr 1;98(4):593-606. doi: 10.1093/biolre/ioy009.

PMID:
29351587
42.

Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting.

Solowij N, Galettis P, Broyd SJ, de Krey P, Martin JH.

Drugs R D. 2018 Mar;18(1):41-44. doi: 10.1007/s40268-017-0225-5.

43.

Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer.

Lucas CJ, Galettis P, Song S, Solowij N, Reuter SE, Schneider J, Martin JH.

Clin Ther. 2018 Sep;40(9):1442-1447. doi: 10.1016/j.clinthera.2017.12.008. Epub 2018 Jan 6.

PMID:
29317112
44.

A new species of <i>Marsipococcus</i> Cockerell &amp; Bueker (Hemiptera: Coccomorpha: Coccidae) from Malaysia.

Łagowska B, Martin JH, Hodgson CJ.

Zootaxa. 2017 Nov 29;4358(2):295-310. doi: 10.11646/zootaxa.4358.2.4.

PMID:
29245470
45.

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis.

Hayward KL, Valery PC, Martin JH, Karmakar A, Patel PJ, Horsfall LU, Tallis CJ, Stuart KA, Wright PL, Smith DD, Irvine KM, Powell EE, Cottrell WN.

World J Gastroenterol. 2017 Oct 28;23(40):7321-7331. doi: 10.3748/wjg.v23.i40.7321.

46.

Comparing subjective and objective evaluation of show jumping competition and warm-up arena surfaces.

Hernlund E, Egenvall A, Hobbs SJ, Peterson ML, Northrop AJ, Bergh A, Martin JH, Roepstorff L.

Vet J. 2017 Sep;227:49-57. doi: 10.1016/j.tvjl.2017.09.001. Epub 2017 Sep 11.

47.

Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.

Head RJ, Fay MF, Cosgrove L, Y C Fung K, Rundle-Thiele D, Martin JH.

Cancer Biol Ther. 2017 Dec 2;18(12):917-926. doi: 10.1080/15384047.2017.1385680. Epub 2017 Nov 20. Review.

49.

Motor system plasticity after unilateral injury in the developing brain.

Williams PTJA, Jiang YQ, Martin JH.

Dev Med Child Neurol. 2017 Dec;59(12):1224-1229. doi: 10.1111/dmcn.13581. Epub 2017 Oct 3. Review.

50.

3D printing of high-strength aluminium alloys.

Martin JH, Yahata BD, Hundley JM, Mayer JA, Schaedler TA, Pollock TM.

Nature. 2017 Sep 20;549(7672):365-369. doi: 10.1038/nature23894.

PMID:
28933439

Supplemental Content

Loading ...
Support Center